AI-generated summary
The authors studied whether near-infrared photobiomodulation combined with porphyrin-based photodynamic therapy could increase toxicity in two head and neck squamous cell carcinoma cell lines, SCC-25 and SCC-4. They report that photobiomodulation enhanced photodynamic therapy in SCC-25 cells by increasing photosensitizer uptake and reactive oxygen species production, but this was not seen in SCC-4 cells. The study was conducted in cell lines only.
- Who or what was studied
- Squamous cell carcinoma cell lines SCC-25 and SCC-4
- Limits stated in the abstract
- The study was conducted in cultured cell lines only, and the effect was observed in one of the two cell lines tested.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Photobiomodulation, Photobiomodulation therapy, Reactive oxygen species, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.